Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVVQV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,358
Award facts
- Contract value 100% obligated
- $8,358.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,358.04 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injections. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This award is a child contract derived from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's DLA prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of diverse medical commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. Dupixent is a biologic treatment for inflammatory conditions including asthma and atopic dermatitis, reflecting the broad therapeutic range of medications supplied through this federal medical supply relationship.
Quick answers
Who was awarded contract SPE2DB25FVVQV?
SPE2DB25FVVQV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FVVQV worth?
The government has obligated $8,358 on SPE2DB25FVVQV.
Is contract SPE2DB25FVVQV an order under another contract?
Yes. SPE2DB25FVVQV is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVVQV competed?
The extent of competition for SPE2DB25FVVQV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award